STATE OF WISCONSIN INVESTMENT BOARD - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 128 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE OF WISCONSIN INVESTMENT BOARD ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$885,753
+25.5%
38,637
-9.8%
0.00%
+50.0%
Q2 2023$706,036
-4.9%
42,816
+2.9%
0.00%0.0%
Q1 2023$742,340
-37.5%
41,611
+2.1%
0.00%
-50.0%
Q4 2022$1,186,873
+25.9%
40,758
+5.9%
0.00%
+33.3%
Q3 2022$943,000
+9.4%
38,505
-81.5%
0.00%
+50.0%
Q2 2022$862,000
-23.6%
207,701
+112.2%
0.00%0.0%
Q1 2022$1,128,000
+133.5%
97,900
+102.3%
0.00%
+100.0%
Q4 2021$483,000
-23.6%
48,4000.0%0.00%0.0%
Q3 2021$632,000
-33.3%
48,4000.0%0.00%
-50.0%
Q2 2021$948,000
-7.9%
48,4000.0%0.00%0.0%
Q1 2021$1,029,000
-28.5%
48,4000.0%0.00%
-33.3%
Q4 2020$1,439,000
+22.1%
48,400
-11.0%
0.00%0.0%
Q3 2020$1,179,000
+5.1%
54,400
+8.2%
0.00%0.0%
Q2 2020$1,122,000
+54.5%
50,300
+5.5%
0.00%
+50.0%
Q1 2020$726,000
-8.1%
47,700
+38.7%
0.00%0.0%
Q4 2019$790,000
+6.3%
34,4000.0%0.00%0.0%
Q3 2019$743,000
+60.1%
34,400
+63.0%
0.00%
+100.0%
Q2 2019$464,000
-17.9%
21,100
+2.4%
0.00%
-50.0%
Q1 2019$565,000
+32.9%
20,600
+30.4%
0.00%
+100.0%
Q4 2018$425,000
+15.5%
15,800
+25.4%
0.00%0.0%
Q3 2018$368,000
-6.6%
12,6000.0%0.00%0.0%
Q2 2018$394,00012,6000.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 909,258$11,875,0002.75%
RA Capital Management 4,871,067$63,616,0000.88%
NEA Management Company, LLC 4,912,306$64,155,0000.76%
Samsara BioCapital, LLC 300,293$3,922,0000.62%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,989,625$25,985,0000.51%
Baker Brothers Advisors 3,863,239$50,454,0000.22%
ACT CAPITAL MANAGEMENT, LLC 31,000$405,0000.21%
Rock Springs Capital Management LP 612,180$7,995,0000.17%
GILDER GAGNON HOWE & CO LLC 1,496,424$19,543,0000.10%
FEDERATED HERMES, INC. 3,011,053$39,324,0000.08%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders